Suppliers / Zhejiang Tasln Biopharma

Zhejiang Tasln Biopharma

China Updated 9 July 2026

Zhejiang Tasln Biopharma is an API manufacturer based in China. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
China, China 3031855648

What they file, and where

Molecule Regulators Docs
Eptifibatide US FDA 1

Also appears on these molecule pages

Eptifibatide API

Questions about Zhejiang Tasln Biopharma

Does Zhejiang Tasln Biopharma hold a US DMF or a CEP?
Zhejiang Tasln Biopharma holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Zhejiang Tasln Biopharma FDA-registered?
One site operated by Zhejiang Tasln Biopharma carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Zhejiang Tasln Biopharma manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Zhejiang Tasln Biopharma make?
1 molecule is on record against Zhejiang Tasln Biopharma, including Eptifibatide. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Tasln Biopharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Alp Pharm Beijing shares 1 molecule PolyPeptide shares 1 molecule Hybio Pharmaceutical shares 1 molecule Sinopep-Allsino Biopharmaceutical shares 1 molecule Chengdu Shengnuo Biopharm shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability